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Recently a number of studies have examined the quality of the data obtained from various 
systems used in the self-monitoring of blood glucose. Many of these studies have used 
parametric statistical techniques such as the Pearson product-moment correlation ( r )  and 
linear regression to evaluate the errors associated with self-monitoring results. These 
statistical methods, while well known and easily computed on modern computers, are often 
inappropriate for evaluating either the amount of error associated with self-monitoring or 
the clinical significance of these errors. For example: 1. a correlation of 1.00 does not 
necessarily mean that the measurements from a self-monitoring system agree with the true 
values and are without error; 2. a correlation close to 0.00 does not necessarily mean that the 
measurements from self-monitoring differ widely from the true values and possess large 
amounts of error; 3. a slope of 1.0 and a y-intercept of 0.0 in a linear regression equation do 
not necessarily mean that the self-monitoring measurements agree with the true values; 4. 
a slope and y-intercept that deviate significantly from 1.0 and 0.0, respectively, do not 
necessarily mean that such measurements differ widely from the true values. The present 
paper illustrates some of the limitations and common misconceptions concerning these 
statistics, and shows that a reliance on these techniques alone can, in certain circumstances, 
lead to misleading estimates of the amount of error associated with self-monitoring systems 
and inappropriate descriptions of the clinical significance of these errors. We would wish to 
discourage the use of these statistics for evaluating the clinical significance of the errors in 
self-monitoring results, and encourage the use of more appropriate analyses such as error 
grid analysis. 
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Introduction 
In the last 8 years, as self-monitoring of blood glucose has 
become a more important part of the management of 
diabetes, there has emerged a growing concern about the 
quality of the data obtained using this procedure outside 
the clinical laboratory.’ This concern has resulted in a 
number of studies that have examined the quality of the 
self-monitoring data obtained by a variety of individuals 
(children, adolescents, and adults with diabetes; parents 
and health professionals) using various reagent strips and 
meters.*-’ ’ 
Most of these studies have examined the quality of the 
self-monitoring data by comparing the blood glucose 
measurements obtained from the self-monitoring system 
with the measurements determined using a laboratory 
method (Beckman Glucose Analyzer 11, YSI Model 23A 
Glucose Analyzer, and others). The laboratory method is 
used to represent the ‘gold standard’ or ’true’ measure of 
blood glucose, and the quality of the data is evaluated by 
examining the extent to which the patient-generated 
Correspondence to: Dr Robert F. Dedrick, University of Michigan 
Medical School, 1500 E. Medical Center Drive/C1?13 Towsley, Box 
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measurements deviate from the ’true’ values. The devi- 
ations from the ’true’ values are viewed as errors in 
the self-monitoring system and may be due to random 
factors (chance variation), systematic factors (bias), or a 
combination of random and systematic factors. Random 
error increases the imprecision of the measurements, 
while systematic error (either constant or proportional) 
increases the inaccuracy of the measurements.18 
While the design of these studies is straightforward, 
there has been some controversy over what methods 
should be used to analyse the data resulting from them. 
Many studies have used statistical methods such as 
the Pearson product-moment correlation ( r )  and linear 
regression to evaluate the error associated with self- 
monitoring, despite the fact that a number of investi- 
gators have noted the limitations of these  method^.'^-^' 
Clarke et a/., for example, have argued that these statis- 
tics evaluate the deviations of the patient-generated 
measurements from their true values ’in ways that may 
not be clinically useful and therefore make it difficult to 
evaluate the clinical significance of a particular product or 
method’.21 
In place of these statistical methods, Cox et a/.’’ have 
developed a systematic and comprehensive graphical 
display technique for evaluating the errors associated 
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with self-monitoring. This technique, which is called error 
grid analysis, displays a scatterplot of the self-monitoring 
results against the laboratory measurements and classi- 
fies the errors in the patient-generated data in terms of 
their clinical significance (Figure I). Clinical significance is 
determined by considering the percent error (deviation) 
between the patient-generated and true measurements 
in relation to the patient’s true glucose level. The major 
principle underlying this display technique is that two 
patient-generated measurements that deviate by the 
same amount from their true values (e.g. 50 Yo) may have 
different clinical meanings depending on the patients’ 
true glucose levels. For example, a 50 ‘Yo underestimate of 
a true value of 3.3 mmol I-’ will not make any difference 
in terms of the treatment actions taken by a patient. 
Under both circumstances (an incorrect blood glucose 
reading of 1.7 mmol I-’ or a correct reading of 
3.3 mmol I-’) the patient will take corrective treatment 
action to raise the blood glucose concentration. How- 
ever, a 50% underestimate when the true value is 
16.7 mmol I-’ will result in the patient not taking action 
to lower a clinically elevated blood glucose level. 
Error grid analysis defines five major zones or cat- 
egories of errors that range from Zone A to Zone E (note 
that Cox and colleag~es’’~ definition of clinical sig- 
nificance reflects the practices and philosophy of the 
University of Virginia Medical Center, but can be adjusted 
to meet the needs of other institutions). Zone A in error 
grid analysis represents clinically accurate measure- 
ments. These measurements are within 20% of the 
laboratory measurements or are in the hypoglycaemic 
range (< 3.9 mmol I-’) when the true glucose levels are 
also in the hypoglycaemic range.20 Zone B represents 
measurements that deviate from the laboratory values by 
more than 20 YO; these measurements, however, would 
lead to either no change in treatment or benign treat- 
ment changes (treatment changes that would maintain 
actual blood glucose levels within the 3.9 mmol I-’ to 
10 mmol I- ’  range). For example, a patient-generated 
measurement of 7.8 mmol I - ’  when the true value is 
5.6 mmol I-’ is in error by 39%, but this error would not 
lead to any corrective treatment action. Zone C refers to 
measurements that deviate from the laboratory by more 
than 20 O/O and ‘would lead to unnecessary corrective 
treatment errors’.2o These unnecessary corrective treat- 
ment errors might result in the actual blood glucose levels 
falling below the 3.9 mmol I-’ level or rising above 
10 mmol I-’. Zone D involves ’potentially dangerous 
failures to detect and treat extreme reference blood glu- 
cose’.*’ These errors occur when the patient-generated 
measurements are within the 3.9 to 10 mmol I-’ range 
but the true glucose levels are outside this target range. 
Zone E represents measurement errors ’that would 
result in erroneous self-treatment’.20 Patient-generated 
measurements in this zone ‘are opposite to the reference 
values, and corresponding treatment decisions would 
therefore be opposite to that called for’.21 For example, a 
patient-generated measurement of 2.2 mmol I-’ when 
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the true value was 11.1 mmol I-’ would lead the patient 
to take action to increase a clinically low blood glucose 
level, when in fact the patient should be taking action to 
lower a clinically elevated blood glucose level. 
The errors in the error grid system represent the total 
deviation of the patient-generated measurement from 
the true values, and are not subdivided into random and 
systematic components. This approach to conceptualiz- 
ing the errors associated with self-monitoring systems 
reflects the clinical orientation of the error grid technique 
and is consistent with the view held by Westgard et a/.22 
that an examination of the total error of a system is more 
medically useful for evaluating the performance of the 
system outside the laboratory. These authors note that 
’the physician thinks rather in terms of the total analytic 
error, which includes both random and systematic com- 
ponents. From his [physician1 point of view, all types of 
analytic error are acceptable as long as the total analytic 
error is less than a specified amount. After all, it makes 
little difference to  the patient whether a laboratory value 
is in error because of random or systematic analytic 
error’ .22 
In using error grid analysis, the error associated with 
the self-monitoring system is evaluated by calculating the 
percentage of self-monitoring measurements that fall 
within each of the five zones. Figure 1 illustrates the use of 
error grid analysis with the hypothetical data contained in 
Table 1, and displays the critical boundaries that define 
the clinical significance of the patient-generated errors. 
As can be seen in this graph, 33 ‘Yo of the self-monitoring 
measurements were in Zone C, 33 ‘YO were in Zone D, and 
33% were in Zone E. None of the patient-generated 
values were clinically accurate or acceptable. 
While error grid analysis represents a powerful tool 
for evaluating the clinical significance of the errors 
associated with self-monitoring and provides a means 
of clarifying the information provided by statistical 
methods, it has not been widely used in published 
research reports examining self-monitoring data gener- 
ated outside the laboratory. In general, many investi- 
gators have continued to rely solely on statistical 
methods to evaluate the errors associated with self- 
monitoring. For example, at the recent Consensus 
Development Conference on Self-Blood Glucose Moni- 
toring (November 19861, six of the 13 abstracts that were 
presented used either correlation or regression tech- 
niques to evaluate the self-monitoring systems, and none 
of the abstracts used error grid analysis. One reason for 
the continued reliance on statistical methods to evaluate 
errors in self-monitoring may be that, while Cox et a/.’’ 
and Clarke et d2’ have made an excellent case for using 
error grid analysis, these individuals and others have not 
gone far enough in clarifying the limitations and potential 
statistical problems with the Pearson product-moment 
correlation and linear regression techniques. Clarke et a/., 
for example, criticized the correlation coefficient as a 
measure of the clinical accuracy of a self-monitoring sys- 
tem, noting that the ’ r  value can be close to unity for large 
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Table 1. Hypothetical glucose values (mmol I-’) from a self-monitoring device and a laboratory method 
illustrating a Pearson product-moment correlation of 1.00 
Laboratory reference Self-monitorin Y O  Error grid Clinical 
































350 D Dangerous 
failure to treat 
350 D Dangerous 
failure to treat 
350 E Erroneous 
treatment 
350 E Erroneous 
treatment 
350 C Unnecessary 
correction 
350 C Unnecessary 
correction 
”Clinical significance is based on error grid analysis.” 
which these techniques may provide misleading infor- 
mation about the amount and clinical significance of the 
errors associated with the self-monitoring system. 
Given the potential dangers in relying solely on stat- 
istical techniques to evaluate the error associated with 
self-monitoring, this paper illustrates some of the limi- 
tations and common misconceptions concerning these 
statistics, and demonstrates that under certain conditions 
these statistics provide misleading estimates of the 
amount of error present in the self-monitoring system. In 
addition, this paper illustrates that these techniques pro- 
vide little information about the clinical significance of the 
self-monitoring errors. Although it is intended primarily 
for investigators examining the performance of self- 
monitoring systems in clinical applications, many of the 
issues discussed are relevant to analytical evaluations 
conducted in the clinical laboratory. 
27 
Labora tory  (mmol / l )  
Figure 1. Example of error grid analysis using the data in Table 1. 
The target range of desirable glucose values established by Cox 
et a/. is 3.9 mmol I-’ to 10.0 mmol I-’. The lower level Zone C 
(zone below the diagonal) ranges from 7.2 mmol I-’ to 
10.0 mmol I-’. Lower level Zone D begins at 13.3 mmol I-’. 
Lower level Zone E begins at 10.0 mmol I-’ 
sets of data when individual data points differ by large 
amounts. In addition, correlation coefficients that evalu- 
ate the entire range of blood glucose may misrepresent 
the true relationship between subsets of data’.21 These 
same authors similarly criticized the linear regression 
technique noting that ‘a slope that approaches unity can- 
not always predict the relationship between two specific 
data points’.*’ While these statements are correct, they 
may not go far enough in explaining the nature of corre- 
lation and regression analysis and the cbnditions under 
INTERPRETATION OF DATA FROM SELF-MONITORING 
Pearson Product-Moment Correlation 
A number of studies have incorrectly used the Pearson 
product-moment correlation ( r )  to measure the extent to 
which the measurements from self-monitoring s stems 
agree with the true values of blood glucose. 
Many of the authors of these studies have incorrectly 
assumed that correlations that approach (or are equal to) 
a positive, perfect correlation ( r  = 1.00) indicate a small 
amount of error in the self-monitoring system, while 
correlation coefficients that approach 0.00 indicate a 
large amount of error. 
These assumptions are incorrect because the Pearson r 
does not provide an estimate of the total amount of error 
associated with a self-monitoring system, but rather only 
provides information about the random error (impre- 
cision) influencing the system. Thus, an r of 1.00 does not 
necessarily mean that the measurements from the self- 
monitoring system are the same, or even close to the 
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Table 2. Hypothetical glucose values (mmol I-’) from a self-monitoring device and a laboratory method 
illustrating a weak correlation (r = 0.25) 
Y O  Error grid CI i n i cal 
value (mrnol I-’) value (mmol 1- 5 ) Deviation analysis zone significance 



















































measurements obtained using the laboratory method. 
For example, the correlation for the hypothetical data 
presented in Table 1 is 1.00 even though each of the 
values from the self-monitoring device deviates from the 
reference by 350 O/o, and each represents a potentially 
dangerous clinical error as defined in the error grid 
system. 
This result can occur because the Pearson r is a statistic 
designed to measure the extent to which pairs of 
measurements are associated, not the extent to which 
measurements agree. While the terms association and 
agreement are frequently used synonymously in every- 
day language, these terms have very different and precise 
meanings in  statistic^.^^ Association represents the extent 
to which pairs of measurements go together according to 
some mathematical rule or function, while agreement 
represents the extent to which pairs of measurements are 
identical. According to these definitions, agreement may 
be viewed as a special case of association. What this 
means is that if two measurements agree they will be 
associated, but two measurements that are associated 
will not necessarily agree. The implication of this fact is 
that if measurements from a self-monitoring system differ 
from a reference (laboratory measurement) by a pro- 
portional amount ( e g  a systematic error of 350 %) or a 
constant amount ( e g  a systematic error of 350 units) the 
correlations will be 1.00 because these measurements, 
although not identical, will exhibit perfect association. 
This association, however, does not mean that there is an 
absence of error in the self-monitoring system. 
The inappropriateness of the Pearson r as a measure of 
the error associated with a self-monitoring system is 
further illustrated by the hypothetical data in Table 2. The 
Pearson correlation for these data is 0.25 despite the fact 
that each of the measurements from the self-monitoring 
system is almost identical to the measurements obtained 
in the laboratory (the largest percent error was 5.5 YO), 
and each is ‘clinically accurate’ as defined by error grid 
analysis. This result can occur because the Pearson r is 
influenced by the variability of the measurements that are 
correlated. Measurements that have little var‘iability will 
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not correlate strongly, and thus if the range (variability) 
of one or more of the measurements is restricted 
(e.g. examining the blood glucose values in the 5.3- 
5.7 mmol I-’ range) the correlation will decrease. Figure 2 
illustrates what happens to the correlation coefficient 
when the range of glucose values under investigation is 
increased. The correlation for the ran e of glucose values 
from 2.0 mmol I - ’  to  14.0 mmol I-‘ is equal to 0.98, 
while the correlations in the 2.0-4.0 mmol I-’, 6.0- 
8.0 mmol I-’, and 12.0--14.0 mmol I - ’  ranges are each 
equal to 0.30. 
r = 0.30 
E l 8  
r =0.30 El 
8 
0 
0 5 10 15 
Loboratory (rnrnol 1-’) 
Figure 2. Scatterplot illustrating the influence of variability 
of blood glucose estimates on the correlation coefficient. 
Correlation for the full range is 0.98 
While it might be argued that investigators examining 
the performance of self-monitoring systems (both within 
the laboratory and in clinical practice) should include a 
representative range of blood glucose values in their per- 
formance assessments, currently there is no agreement 
on what constitutes a ’representative’ range of blood 
glucose values. The implication of this fact is that investi- 
gators will use different ranges of values, thus making the 
interpretation of the Pearson r problematic. 
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These examples illustrate that the Pearson r does not 
provide information about the amount of systematic 
error associated with a self-monitoring system. Further- 
more, while the Pearson correlation provides some infor- 
mation about random error (imprecision) this statistic is 
difficult to interpret because the size of the correlation is  
influenced by the range of the measurements. Given 
these facts it is clear that this statistic should not be used 
to quantify the error associated with a self-monitoring 
system, and consequently should not be used to evaluate 
the clinical significance of the errors that occur in using 
self-monitoring. 
Linear Regression 
Least squares linear regression has also been widely used 
to evaluate the quality of the data obtained from various 
self-monitoring systems.5~6~9~12~14~16 These studies have 
examined the amount of error associated with self- 
monitoring by fitting a linear regression equation to the 
blood glucose values obtained using a given method of 
self-monitoring and the corresponding blood glucose 
measurements obtained in the laboratory. The linear 
regression line, represented by the equation y = ax + b, 
where x i s  the independent variable (‘gold standard’ or 
laboratory measurement), y is the predicted value for 
the dependent variable (self-monitoring method under 
evaluation), b is the y-intercept, and a is the slope of the 
regression line, is. determined using the least squares 
criterion. The least squares criterion involves selecting the 
slope and y-intercept so that the regression line provides 
the best fit of the data (i.e. the sum of the squared errors 
around the regression line is as small as possible). 
Once the regression line is fitted to the data, the quality 
of the data from the self-monitoring system has generally 
been evaluated by examining the values of the slope and 
y-intercept. Many investigators have incorrectly assumed 
that a slope of 1.0 and a y-intercept of 0.0 (i.e. a line that 
goes through the axis at the origin and forms a 45 degree 
angle) indicate that the glucose values determined using a 
given method of self-monitoring are identical to the 
values determined in the laboratory and are without 
error. In addition, it has been incorrectly assumed that a 
slope and/or y-intercept that differ from 1.0 and 0.0, 
respectively, indicate that there are major discrepancies 
(error) between the measurements obtained using a 
self-monitoring device and those obtained using the 
laboratory method. 
The flaw in the first assumption is that while a self- 
monitoring system that has no error will have values of 1 .O 
and 0.0 for the slope and y-intercept, respectively, a slope 
of 1.0 and a y-intercept of 0.0 do not necessarily mean 
that the measurements from the self-monitoring system 
are the same, or even close to the measurements 
obtained using a laboratory method. Table 3 illustrates a 
case in which the regression line has a slope of 1.0 and a 
y-intercept of 0.0 despite the fact that the self-monitoring 
measurements and the laboratory measurements are not 
identical. This result can occur because the slope and 
y-intercept do not provide an estimate of the total error 
associated with self-monitoring, but rather only provide 
information about the amount of systematic error (inac- 
curacy) influencing the system. In this example, the 
discrepancies between the self-monitoring measure- 
ments and the true values are due to random factors 
(imprecision) and thus the values of the slope and 
y-intercept, which are not sensitive to these errors, do 
not provide information about the level of agreement 
between the patient-generated values and the true 
values. In order to obtain a more complete description of 
the errors influencing the self-monitoring system it would 
be necessary to compute the standard error of estimate 
for the regression line, in addition to determining the 
slope and y-intercept. The standard error of estimate is 
the standard deviation of the points around the re- 
gression line and provides a quantitative estimate of the 
amount of random error influencing the self-monitoring 
system. The value of the standard error of estimate for this 
example is 3.1 mmol I-’ (standard deviation of the self- 
monitoring values is 4.2 mmol I-’) which would indicate 
that there is a relatively large amount of random error in 
the self-monitoring measurements. This value, however, 
like the slope and y-intercept, provides little information 
to the clinician about the clinical significance of the errors 
in the self-monitoring system. In contrast, the results of 
error grid analysis indicate that 8 out of the 10 errors in the 
patient-generated data are benign errors (Zone B) while 
only one measurement represents a dangerous clinical 
error 6.e. failure to detect and treat error, Zone D). 
The assumption that the slope and y-intercept provide 
information about the amount of error in the self- 
monitoring system (e.g. a slope and/or y-intercept that 
differ from 1 .O and 0.0, respectively, are generally believed 
to indicate that there is major error in the self-monitoring 
results) may be incorrect under certain conditions. One 
of these conditions is when there are outliers or extreme 
values in the data. An outlier is usually defined as a 
measurement that deviates from the average blood 
glucose measurement by more than three standard 
deviations, and it may reflect a truly anomalous measure- 
ment or it may be the result of a problem in collecting or 
recording the data. Outliers in the data will result in poor 
estimates of the slope and y-intercept, and consequently 
will produce misleading information about the amount of 
error associated with the use of a self-monitoring device. 
The data in Table 4 illustrate how even one extreme value 
or outlier in the measurements can have a large effect on 
the values of the slope and y-intercept. The regression 
line for these data has a y-intercept of - 3.2 and a slope 
of 2.0 (y = 2 . 0 ~  +- 3.2) and would suggest that there 
are serious discrepancies between the self-monitoring 
and laboratory values. Upon closer examination of the 
measurements, however, it is apparent that there is per- 
fect agreement for all but one measurement (an outlier). 
While outliers have more pronounced effects when the 
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Table 3. Hypothetical glucose values (mmol I-’) from a self-monitoring device and a laboratory method 
illustrating a regression line with a slope of 1.0 and a y-intercept of 0.0 
Laboratory reference Self-monitorin % Error grid Clinical 





















































Table 4. Hypothetical glucose values (mmol I-’) from a self-monitoring device and a laboratory method 
illustrating the influence of an outlier 
Laboratory reference Self-monitorin % Error grid Clinical 




















































sample of measurements is small, outliers in large data 
sets can also affect the values of the slope and y-intercept, 
thus leading to  misleading conclusions about the errors 
associated with a self-monitoring device. This issue is 
relevant to  investigators examining the performance of 
self-monitoring systems both within the laboratory and in 
clinical practice. 
A second condition that can seriously affect the 
estimates of the slope and y-intercept is a nonlinear 
relationship between the laboratory and self-monitoring 
measurements. If a curvilinear relationship exists between 
these measurements the least squares estimates of the 
slope and y-intercept will be distorted and consequently 
the estimates of the amount of error associated with the 
self-monitoring results will be inaccurate. 
Conclusions 
The Pearson product-moment correlation and linear 
regression technique are two of the most widely known 
and used statistical techniques, and are frequently used 
to  evaluate the quality of the data obtained from self- 
monitoring systems. This paper has presented examples 
illustrating the limitations of these techniques and has 
attempted to  dispel some of the incorrect notions con- 
cerning these statistics. In particular, it has been shown 
that a Pearson r of 1.00 or a regression equation with a 
slope of 1.0 and a y-intercept of 0.0 does not necessarily 
mean that the self-monitoring measurements are without 
error. In addition, this paper has shown that a Pearson r 
close to 0.0 or a regression line with a slope and y-inter- 
cept that differ significantly from 1.0 and 0.0, respectively, 
does not necessarily mean that the self-monitoring 
measurements deviate greatly from the true values. 
In view of the limitations of the Pearson r, this statistic 
should not be used to  evaluate either the amount of error 
associated with a self-monitoring system or the clinical 
significance of the errors. In addition, it is argued that 
linear regression should not be used to  provide a quanti- 
tative estimate of the amount of error associated with a 
self-monitoring system if any of the following conditions 
are present: 
1. outliers in the data; 
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2. nonlinear relationship between the self-monitoring 
3. a restricted range in the blood glucose measurements. 
These conditions will lead to distorted estimates of the 
slope and y-intercept and misleading descriptions of t he  
amount of error associated wi th  the self-monitoring 
results. If these conditions are no t  present the slope, 
y-intercept, and standard error of estimate can be used 
t o  quantify the amount of proportional, constant, and 
random error, respectively. This information by itself, 
however, cannot be used t o  evaluate the  clinical signifi- 
cance of the errors in the self-monitoring system. As has 
been shown throughout this paper, the meaning and 
clinical significance of the self-monitoring errors can only 
be determined by examining the magnitude of the errors 
in relation to the actual blood glucose values. Currently, 
the only technique that exists that  takes into account 
these factors is  error grid a n a l y s i ~ , ~ ~ - ~ ~  and therefore, 
we would strongly recommend the use of this technique 
t o  determine the clinical significance of any errors in 
self-monitoring results. 
and laboratory measurements; 
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